October 28th, 2013
In the past, cardiovascular risk has been linked to the radiation dose received by breast cancer patients. Now, a new study published in JAMA Internal Medicine attempts to calculate the cardiac risk of breast cancer patients today undergoing current radiotherapy protocols. David J. Brenner and colleagues calculated the excess cardiac risk for 48 patients who received radiotherapy at New […]
August 5th, 2013
A new observational study raises the possibility that calcium-channel blockers (CCBs) may be associated with a higher risk for breast cancer. Although previous studies examining this relationship have failed to turn up convincing evidence of a link, the authors of a paper published in JAMA Internal Medicine state that their study is the first to look at […]
April 17th, 2013
What to tell women with breast cancer about the cardiovascular risks of radiation therapy for breast cancer.
April 5th, 2013
Our panel sketches out the scope of this growing discipline.
March 18th, 2013
This week’s topics include the association between smoking cessation and weight change with CV disease among those with and without diabetes, the risk of ischemic heart disease in women after radiotherapy for breast cancer, and more.
March 13th, 2013
The increased risk of radiotherapy for breast cancer seen in this NEJM study may just be the tip of the iceberg.
March 13th, 2012
For ages, myocardial infarction (MI) has been dismissed as an ‘old man’s disease’. However, not only is it one of the leading causes of mortality in old women, it also afflicts a sizeable proportion of young women. Data from the American Heart Association and the Centers for Disease Control and Prevention suggest that more than 10,000 […]
January 6th, 2011
A meta-analysis in the Journal of Clinical Oncology suggests that bevacizumab (Avastin) significantly raises the risk for heart failure when given to patients with breast cancer. Toni Choueiri and colleagues analyzed data from 3,784 patients and found a significant increase in the incidence of heart failure among those taking bevacizumab compared with those taking placebo […]